Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Avoid using GLP-1 receptor agonists if you or any family members have had MTC, or if you have a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
The SURMOUNT-1 trial showed approximately 3 to 4 percent body weight loss by week eight across all dose groups
Benefits for Gut Health: Targets pathogens without harming beneficial bacteria Helps eliminate mold, yeast, and biofilm Improves immune surveillance in the gut lining Supports wound healing and epithelial integrity Clinical Context: LL-37 is ideal for patients with dysbiosis, recurrent infections, SIFO (small intestinal fungal overgrowth), or mold-related illness
Psychiatry 83, 569578
US$ 22.92
US$ 22.32
US$ 23.86
US$ 27.60
